Replies to post #99224 on Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

Clearly, they have had CR's.

AXAL Phase 2 Study in India: Prolonged Survival and Tumor Response in Randomized, Multicenter Phase 2 Study in Recurrent/ Refractory CC Illustrated the Promise of LmTechnology1?34.9% 12-month survival rate (38/109), 24.8% (27/109) 18-month survival rate, 3 confirmed CRs observed (RECIST 1.1)

[hovacre]

Well, there are drugs out there with only rare CRs that are nevertheless highly effective (see ibrutinib). But it takes a lot of effort to prove that right.